drugset / Trial / NCT06966245

External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia

NCT06966245

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a single-center, double-blind, randomized clinical trial to explore the efficacy and safety of external mastalgia-oil versus placebo in premenopausal women with severe mastalgia.

Timeline

Start
2025-06-08
Primary completion
2027-06-01
Completion
2027-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject mastalgia-oil Unknown 1 ml Topical

Indications

No indication recorded.